FDA To Convene Workshop On Using Ablation Therapy To Treat Certain Lung Cancers
Executive Summary
The US regulatory agency will hold a two-day online workshop in April on how transbronchoscopic thermal ablation devices may be developed to treat intermediate-stage lung tumors known as oligometastases to the lung (OML).